Sandoval, K. E., Farr, S. A., Banks, W. A., Crider, A. M., Morley, J. E., & Witt, K. A. (2013). Somatostatin receptor subtype-4 agonist NNC 26-9100 mitigates the effect of soluble Aβ(42) oligomers via a metalloproteinase-dependent mechanism.
Citação norma ChicagoSandoval, Karin E., Susan A. Farr, William A. Banks, Albert M. Crider, John E. Morley, and Ken A. Witt. Somatostatin Receptor Subtype-4 Agonist NNC 26-9100 Mitigates the Effect of Soluble Aβ(42) Oligomers Via a Metalloproteinase-dependent Mechanism. 2013.
Deismireacht MLASandoval, Karin E., et al. Somatostatin Receptor Subtype-4 Agonist NNC 26-9100 Mitigates the Effect of Soluble Aβ(42) Oligomers Via a Metalloproteinase-dependent Mechanism. 2013.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.